Peter Ginsberg, MBA
Peter Ginsberg joined the Biotechnology Center as vice president of Business & Technology Development in 2010. In this role, he leads the Center’s investments in emerging life science companies, including animal health and agricultural biotech companies.
Previously, Ginsberg headed business development and strategic planning for SurModics, a publicly traded and profitable leader in the field of drug delivery, where he led the acquisition of two companies and was responsible for the company’s investment portfolio. Ginsberg also spent six years as an institutional investor (most recently as head of healthcare equity investments at Deephaven Capital Management) and nine years as a sell-side biotech analyst (most recently as managing director at Piper Jaffray where he was named a Wall Street Journal All-Star).
He currently serves on the advisory board of the University of North Carolina at Chapel Hill's Kenan-Flagler’s Applied Investment Management program and as an Entrepreneur Affiliate at Duke University’s Fuqua School of Business. Ginsberg earned an A.B. in Economics from Princeton University and an MBA from the Tuck School of Business at Dartmouth College.